Close

Akari Therapeutcis (AKTX) Receives Orphan Drug Designation for Treatment of Paroxysmal Nocturnal Hemoglobinuria

Go back to Akari Therapeutcis (AKTX) Receives Orphan Drug Designation for Treatment of Paroxysmal Nocturnal Hemoglobinuria